Cargando…
Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence
BACKGROUND: Antinuclear antibodies are useful diagnostic tools in several autoimmune diseases. However, the routine detection of nuclear envelope autoantibodies using immunofluorescence (IF) is not always easy to perform in patients' sera because of the presence of autoantibodies to other nucle...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574344/ https://www.ncbi.nlm.nih.gov/pubmed/16956395 http://dx.doi.org/10.1186/1471-2172-7-20 |
_version_ | 1782130291169558528 |
---|---|
author | Tsiakalou, Vagia Tsangaridou, Elena Polioudaki, Hara Nifli, Artemissia-Phoebe Koulentaki, Meri Akoumianaki, Tonia Kouroumalis, Elias Castanas, Elias Theodoropoulos, Panayiotis A |
author_facet | Tsiakalou, Vagia Tsangaridou, Elena Polioudaki, Hara Nifli, Artemissia-Phoebe Koulentaki, Meri Akoumianaki, Tonia Kouroumalis, Elias Castanas, Elias Theodoropoulos, Panayiotis A |
author_sort | Tsiakalou, Vagia |
collection | PubMed |
description | BACKGROUND: Antinuclear antibodies are useful diagnostic tools in several autoimmune diseases. However, the routine detection of nuclear envelope autoantibodies using immunofluorescence (IF) is not always easy to perform in patients' sera because of the presence of autoantibodies to other nuclear and cytoplasmic components which could mask the characteristic rim-like pattern of nuclear envelope autoantibodies. This is particularly common in sera from patients with primary biliary cirrhosis (PBC), which generaly have high titres of anti-mitochondrial antibodies. Therefore, we have assayed a number of commercial slides and alternative fixation conditions to optimize the detection of anti-nuclear envelope antibodies (ANEA) in PBC sera. METHODS: We have explored the presence of ANEA in 33 sera from patients with established PBC using three different Hep2 commercial slides and home-made slides with HeLa and Hep2 cells fixed with methanol, ethanol, 1% or 4% formaldehyde. RESULTS: We observed that the IF pattern was related to the cell type used (Hep2 or HeLa), the manufacturer and the cell fixation scheme. When both cell lines were fixed with 1% formaldehyde, the intensity of the cytoplasmic staining was considerably decreased regardless to the serum sample, whereas the prevalence of cytoplasmic autoantibodies was significantly lowered, as compared to any of the Hep2 commercial slide and fixation used. In addition, the prevalence of ANEA was importantly increased in formaldehyde-fixed cells. CONCLUSION: Immunofluorescence using appropriately fixed cells represent an easy, no time-consuming and low cost technique for the routine screening of sera for ANEA. Detection of ANEA is shown to be more efficient using formaldehyde-fixed cells instead of commercially available Hep2 cells. |
format | Text |
id | pubmed-1574344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15743442006-09-23 Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence Tsiakalou, Vagia Tsangaridou, Elena Polioudaki, Hara Nifli, Artemissia-Phoebe Koulentaki, Meri Akoumianaki, Tonia Kouroumalis, Elias Castanas, Elias Theodoropoulos, Panayiotis A BMC Immunol Methodology Article BACKGROUND: Antinuclear antibodies are useful diagnostic tools in several autoimmune diseases. However, the routine detection of nuclear envelope autoantibodies using immunofluorescence (IF) is not always easy to perform in patients' sera because of the presence of autoantibodies to other nuclear and cytoplasmic components which could mask the characteristic rim-like pattern of nuclear envelope autoantibodies. This is particularly common in sera from patients with primary biliary cirrhosis (PBC), which generaly have high titres of anti-mitochondrial antibodies. Therefore, we have assayed a number of commercial slides and alternative fixation conditions to optimize the detection of anti-nuclear envelope antibodies (ANEA) in PBC sera. METHODS: We have explored the presence of ANEA in 33 sera from patients with established PBC using three different Hep2 commercial slides and home-made slides with HeLa and Hep2 cells fixed with methanol, ethanol, 1% or 4% formaldehyde. RESULTS: We observed that the IF pattern was related to the cell type used (Hep2 or HeLa), the manufacturer and the cell fixation scheme. When both cell lines were fixed with 1% formaldehyde, the intensity of the cytoplasmic staining was considerably decreased regardless to the serum sample, whereas the prevalence of cytoplasmic autoantibodies was significantly lowered, as compared to any of the Hep2 commercial slide and fixation used. In addition, the prevalence of ANEA was importantly increased in formaldehyde-fixed cells. CONCLUSION: Immunofluorescence using appropriately fixed cells represent an easy, no time-consuming and low cost technique for the routine screening of sera for ANEA. Detection of ANEA is shown to be more efficient using formaldehyde-fixed cells instead of commercially available Hep2 cells. BioMed Central 2006-09-06 /pmc/articles/PMC1574344/ /pubmed/16956395 http://dx.doi.org/10.1186/1471-2172-7-20 Text en Copyright © 2006 Tsiakalou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Tsiakalou, Vagia Tsangaridou, Elena Polioudaki, Hara Nifli, Artemissia-Phoebe Koulentaki, Meri Akoumianaki, Tonia Kouroumalis, Elias Castanas, Elias Theodoropoulos, Panayiotis A Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title | Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title_full | Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title_fullStr | Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title_full_unstemmed | Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title_short | Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
title_sort | optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574344/ https://www.ncbi.nlm.nih.gov/pubmed/16956395 http://dx.doi.org/10.1186/1471-2172-7-20 |
work_keys_str_mv | AT tsiakalouvagia optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT tsangaridouelena optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT polioudakihara optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT nifliartemissiaphoebe optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT koulentakimeri optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT akoumianakitonia optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT kouroumaliselias optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT castanaselias optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence AT theodoropoulospanayiotisa optimizeddetectionofcirculatingantinuclearenvelopeautoantibodiesbyimmunofluorescence |